Skip to content
healthcare.dev

dihydroergotamine mesylate

NDC 36000-300, dihydroergotamine mesylate, injection, solution, from Baxter Healthcare Corporation.

Product NDC
36000-300
Status
Listed
Labeler
Baxter Healthcare Corporation
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216747
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/36000-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIHYDROERGOTAMINE MESYLATE1 mg/mL

Pharmacologic classes

Ergotamine Derivative [EPC]; Ergotamines [CS]

Package NDCNDC-11Package
36000-300-103600003001010 AMPULE in 1 CARTON (36000-300-10) / 1 mL in 1 AMPULE (36000-300-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f87dcd07-90ef-4e37-853e-7a5911a038b1

Use it

Look up 36000-300 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/36000-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 36000-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.